Harbin Pharmaceutical Group Co Ltd (600664) — Long-term Investment Intensity
Harbin Pharmaceutical Group Co Ltd (600664) has a Long-term Investment Intensity of 7.5% as of September 2019. Long-term investments of CN¥888.94 Million represent 7.5% of total assets of CN¥11.92 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check financial resilience of Harbin Pharmaceutical Group Co Ltd to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Harbin Pharmaceutical Group Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Harbin Pharmaceutical Group Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 7.5%, reflecting long-term investments of CN¥888.94 Million against total assets of CN¥11.92 Billion CNY. For the complete balance sheet picture, see balance sheet size of Harbin Pharmaceutical Group Co Ltd.
Annual Long-term Investment Intensity for Harbin Pharmaceutical Group Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Harbin Pharmaceutical Group Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 600664 current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 2.9% | CN¥344.37 Million | CN¥11.90 Billion | ▲ +2.7 pp |
| 2017 | 0.2% | CN¥32.06 Million | CN¥13.70 Billion | ▲ +0.0 pp |
| 2016 | 0.2% | CN¥33.33 Million | CN¥15.05 Billion | ▼ -0.1 pp |
| 2015 | 0.3% | CN¥44.95 Million | CN¥13.77 Billion | — |